Showing results (1231-1240 of 1,378) with videos related to
Sort By:
Pageof 138
Cell and Tissue Banking|September 10, 2005
Challenges in the testing of non-heart-beating cadavers for viral markers: implications for the safety of tissue donorsDavid Padley, Morag Ferguson, Ruth M Warwick, et al.Cell and Tissue Banking|September 10, 2005
Bacterial contamination of tissue allografts - experiences of the donor tissue bank of VictoriaLyn Ireland, Denis SpelmanCell and Tissue Banking|September 10, 2005
Irradiation as a safety procedure in tissue bankingAnna Dziedzic-Goclawska, Artur Kaminski, Izabela Uhrynowska-Tyszkiewicz, et al.Cell and Tissue Banking|September 10, 2005
Sufficient penetration of peracetic acid into drilled human femoral headsH Brosig, H-J Jacker, H-H Borchert, et al.Cell and Tissue Banking|June 21, 2006
When do tissues and cells become products? Regulatory oversight of emerging biological therapiesAlbert FarrugiaCell and Tissue Banking|December 2, 2009
Cost-effectiveness of homograft heart valve replacement surgery: an introductory studyMohsen Yaghoubi, Hamid Reza Aghayan, Babak Arjmand, et al.Cell and Tissue Banking|May 26, 2025
Bioburden of postmortem bone tissues with a procurement time exceeding 36 hChristian Braun, Matthias Löwel, Miriam Heuer, et al.Cell and Tissue Banking|July 10, 2025
10-years analysis of cryobag fracture in a large inventory of cellular therapy products: rates and risk factorsAndré Rolim Belisário, Laura Teixeira Mendonça, Maurício Colombini Martins, et al.Cell and Tissue Banking|April 24, 2025
Wound healing by enhancing cell proliferation: a thermoreversible formulation containing raloxifeneSubodh Kumar, Yogesh Kumar VermaCell and Tissue Banking|September 8, 2025
Increased serologic reactivity with automated CMIA testing and its implications for deceased donor eligibility determination in the United StatesSara O Dionne, Hillary C S R Akana, Michael Real, et al.Pageof 138